Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 7, Pages 1642-1654
Publisher
Wiley
Online
2013-11-06
DOI
10.1111/bph.12504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes
- (2013) D J Baker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus
- (2013) A. Kiyosue et al. DIABETES OBESITY & METABOLISM
- Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin
- (2013) J. P. H. Wilding et al. DIABETES OBESITY & METABOLISM
- Effects of a glucokinase activator on hepatic intermediary metabolism: study with13C-isotopomer-based metabolomics
- (2012) Itzhak Nissim et al. BIOCHEMICAL JOURNAL
- Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
- (2012) Matthew G Rees et al. BRITISH JOURNAL OF PHARMACOLOGY
- The use of animal models in diabetes research
- (2012) Aileen JF King BRITISH JOURNAL OF PHARMACOLOGY
- Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans
- (2012) Frédéric De Ceuninck et al. BRITISH JOURNAL OF PHARMACOLOGY
- Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus
- (2012) L. A. Morrow et al. DIABETES OBESITY & METABOLISM
- Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp
- (2012) M. Sjöstrand et al. DIABETES OBESITY & METABOLISM
- Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat
- (2012) M. Futamura et al. DIABETOLOGIA
- Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clamp
- (2012) Hans Ericsson et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pancreatic Beta Cells in Very Old Mice Retain Capacity for Compensatory Proliferation
- (2012) Miri Stolovich-Rain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucokinase Activators AZD6370 and AZD1656 Do Not Affect the Central Counterregulatory Response to Hypoglycemia in Healthy Males
- (2012) Ensio Norjavaara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Compensatory Recovery of Blood Glucose Levels in KKAy Mice Fed a High-Fat Diet: Insulin-Sparing Effects of PACAP Overexpression in β Cells
- (2012) Yusuke Sakurai et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Property based optimisation of glucokinase activators – discovery of the phase IIb clinical candidate AZD1656
- (2012) Michael J. Waring et al. MedChemComm
- Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis
- (2011) Francis J. Bourbonais et al. BIOCHEMICAL JOURNAL
- Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
- (2011) G. E. Meininger et al. DIABETES CARE
- Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice
- (2011) Maria Sörhede Winzell et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacokinetic and Pharmacodynamic Properties of the Glucokinase Activator MK-0941 in Rodent Models of Type 2 Diabetes and Healthy Dogs
- (2011) J.-i. Eiki et al. MOLECULAR PHARMACOLOGY
- Overcoming retinoic acid receptor-α based testicular toxicity in the optimisation of glucokinase activators
- (2011) Michael J. Waring et al. MedChemComm
- Matrix-based multiparameter optimisation of glucokinase activators: the discovery of AZD1092
- (2011) Michael J. Waring et al. MedChemComm
- Effect of long-term treatment with a small-molecule glucokinase activator on glucose metabolism, lipid profiles and hepatic function
- (2011) Akinobu Nakamura et al. Journal of Diabetes Investigation
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat
- (2010) Sumika Ohyama et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study
- (2010) Riccardo C. Bonadonna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia
- (2009) Kara K. Osbak et al. HUMAN MUTATION
- Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes
- (2009) Gregory R. Bebernitz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assessing the potential of glucokinase activators in diabetes therapy
- (2009) Franz M. Matschinsky NATURE REVIEWS DRUG DISCOVERY
- Glucokinase and molecular aspects of liver glycogen metabolism
- (2008) Loranne Agius BIOCHEMICAL JOURNAL
- Impact of Small-Molecule Glucokinase Activator on Glucose Metabolism and β-Cell Mass
- (2008) Akinobu Nakamura et al. ENDOCRINOLOGY
- Glucokinase activators in diabetes management
- (2008) Matthew Coghlan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice
- (2007) T. Gorman et al. DIABETES OBESITY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started